Jump to content

Charles N. Serhan

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by William Avery (talk | contribs) at 17:38, 17 September 2023 (MOS:HEAD; MOS:'). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Charles Nicholas Serhan is the Simon Gelman Professor of Anaesthesia (Biochemistry and Molecular Pharmacology) at Harvard Medical School and a Professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine.[1] Serhan is the Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women's Hospital.[1]

Education

Serhan completed his Bachelor of Science in Biochemistry at State University of New York at Stony Brook in 1978.[2] In 1982, Serhan earned a doctorate in Experimental Pathology and Medical Sciences from New York University School of Medicine.[2] Following his graduation, Serhan began a postdoctoral fellowship at the Karolinska Institute in Stockholm, Sweden under the mentorship of Bengt Samuelsson.[3] Serhan has also received honorary degrees from Harvard University,[1] University College Dublin,[4] and Queen Mary College, University of London.[5]

Career

The focus of Serhan's research are Specialized Pro-Resolving Mediators (SPMs), which are "inflammation-fighting molecules in the body derived from essential fatty acids".[6] While working with Mats Hamberg and Bengt Samuelsson at the Karolinska Institute, Serhan helped discover lipoxin[7] the first of the SPMs to be elucidated.[8] Since this initial discovery, Serhan has identified additional mediators including Resolvins, Maresins, and Protectins.[9]

Serhan became a faculty member at Harvard Medical School in 1987[3] and the Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women's Hospital (CET&RI).[1] The CET&RI's mission is: "To identify novel mediators, pathways, and their cellular receptors and targets critical in promoting resolution of inflammation and reperfusion tissue injury and establish their relation to human disease".[10]

Awards and honors

Serhan was awarded the John Vane Medal from The William Harvey Research Institute in 2008.[11] In 2016, he received the Ross Prize in Molecular Medicine.[12] He was awarded the International Eicosanoid Research Foundation's 2017 Lifetime Achievement Award.[13] Serhan was the American Society for Investigative Pathology (ASIP) Rous-Whipple Award recipient in 2018[14] and became an Honorary Life Member of the Society for Leukocyte Biology in 2019.[15] In 2022, Serhan delivered the Hans L. Falk Memorial Lecture at the National Institute of Environmental Health Sciences.[16]

References

  1. ^ a b c d "Prof. Charles Serhan, PhD, Research - Brigham and Women's Hospital". www.brighamandwomens.org. Retrieved 2022-12-27.
  2. ^ a b "Charles Serhan | Harvard Medical School - Academia.edu". hms-harvard.academia.edu. Retrieved 2022-12-27.
  3. ^ a b "Charles N. Serhan, Ph.D." www.science.org. Retrieved 2022-12-27.
  4. ^ "Charles Serhan - UCD President's Office". www.ucd.ie. Retrieved 2022-12-27.
  5. ^ "Fellows - Queen Mary University of London". www.qmul.ac.uk. Retrieved 2022-12-27.
  6. ^ Communication, Brigham Office of Strategic (2021-03-11). "Your Food, Your Genes, and COVID-19: Q&A with Charles N. Serhan". Brigham Clinical & Research News. Retrieved 2022-12-27.
  7. ^ Serhan, C N; Hamberg, M; Samuelsson, B (1984). "Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes". Proc Natl Acad Sci USA. 81 (17): 5335–5339. Bibcode:1984PNAS...81.5335S. doi:10.1073/pnas.81.17.5335. PMC 391698. PMID 6089195.
  8. ^ "The end of inflammation? New approach could treat dozens of diseases". National Geographic. 2022-03-04. Retrieved 2022-12-27.
  9. ^ Research Features (2017-06-19). "Lipid mediators put an end to inflammation". Research Features. Retrieved 2022-12-27.
  10. ^ "Serhan Lab – Brigham and Women's Hospital". Retrieved 2022-12-27.
  11. ^ "Award Winners - The William Harvey Research Institute - Faculty of Medicine and Dentistry". www.qmul.ac.uk. Retrieved 2022-12-27.
  12. ^ Gentile, Marie (2016-06-02). "Inflammation Researcher to Receive 2016 Ross Prize". The New York Academy of Sciences. Retrieved 2022-12-27.
  13. ^ "ACHIEVEMENT AWARD – Bioactive Lipids in Cancer, Inflammation and Related Diseases". Retrieved 2022-12-27.
  14. ^ "Dr. Charles N. Serhan Receives the ASIP 2018 Rous-Whipple Award". www.newswise.com. Retrieved 2022-12-27.
  15. ^ "Honorary Life Members". www.leukocytebiology.org. Retrieved 2022-12-27.
  16. ^ "Falk Memorial Lecture focuses on how inflammation ends (Environmental Factor, April 2022)". National Institute of Environmental Health Sciences. Retrieved 2022-12-27.

Serhan Lab Website